Restatement of Certain Consolidated Financial Statements (Details) (USD $)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Effect of restatement on the Company's balance sheet              
Warrant liability $ 1,546,050   $ 1,546,050   $ 937,000     
Total liabilities 6,610,002   6,610,002   6,029,870 2,961,167  
Additional paid-in capital 9,117,897   9,117,897   8,256,864 2,730,659  
Accumulated deficit (7,412,296)   (7,412,296)   (3,684,743) (2,091,570)  
Total Stockholders' Equity 1,744,256   1,744,256   4,610,701 664,697 1,675,470
Effects of the restatement on the Company’s statement of operations              
Mark-to-market adjustment on warrant liability     (609,050) 2,014,575 2,038,000    
Total Other Income (Expense)       (16,885) 3,909 3,909 12,892  
Net loss before income tax 302,306 121,185 (3,727,553) (50,328) (1,593,173) (1,154,474)  
Net income (loss) 302,306 121,185 (3,727,553) (50,328) (1,593,173) (1,167,070)  
Basic net loss per share         $ (0.04) $ (0.04)  
Effect of restatement on the Company's statement of changes in stockholders' equity              
Additional paid-in capital 9,117,897   9,117,897   8,256,864 2,730,659  
Accumulated deficit (7,412,296)   (7,412,296)   (3,684,743) (2,091,570)  
Total Stockholders' Equity 1,744,256   1,744,256   4,610,701 664,697 1,675,470
Effect of restatement on company's statement of cash flows              
Net income (loss) 302,306 121,185 (3,727,553) (50,328) (1,593,173) (1,167,070)  
Mark-to-market adjustment on warrant liability     609,050 (2,014,575) (2,038,000)    
As Originally Reported [Member]
              
Effect of restatement on the Company's balance sheet              
Warrant liability               
Total liabilities         5,154,442    
Additional paid-in capital         11,231,864    
Accumulated deficit         (5,722,743)    
Total Stockholders' Equity         5,547,701    
Effects of the restatement on the Company’s statement of operations              
Mark-to-market adjustment on warrant liability                 
Total Other Income (Expense)         32,767    
Net loss before income tax   (511,290)   (2,064,903) (3,631,173)    
Net income (loss)   (511,290)   (2,064,903) (3,631,173)    
Basic net loss per share   $ (0.01)   $ (0.06) $ (0.10)    
Effect of restatement on the Company's statement of changes in stockholders' equity              
Additional paid-in capital         11,231,864    
Accumulated deficit         (5,722,743)    
Total Stockholders' Equity         5,547,701    
Effect of restatement on company's statement of cash flows              
Net income (loss)   (511,290)   (2,064,903) (3,631,173)    
Mark-to-market adjustment on warrant liability                 
Effect of Restatement [Member]
              
Effect of restatement on the Company's balance sheet              
Warrant liability         937,000    
Total liabilities         937,000    
Additional paid-in capital         (2,975,000)    
Accumulated deficit         2,038,000    
Total Stockholders' Equity         (937,000)    
Effects of the restatement on the Company’s statement of operations              
Mark-to-market adjustment on warrant liability   632,475   2,014,575 2,038,000    
Total Other Income (Expense)         2,038,000    
Net loss before income tax   632,475   2,014,575 2,038,000    
Net income (loss)   632,475   2,014,575 2,038,000    
Basic net loss per share   $ 0.01   $ 0.06 $ 0.06    
Effect of restatement on the Company's statement of changes in stockholders' equity              
Additional paid-in capital         (2,975,000)    
Accumulated deficit         2,038,000    
Total Stockholders' Equity         (937,000)    
Effect of restatement on company's statement of cash flows              
Net income (loss)   632,475   2,014,575 2,038,000    
Mark-to-market adjustment on warrant liability   (632,475)   (2,014,575) (2,038,000)    
As Restated [Member]
              
Effect of restatement on the Company's balance sheet              
Warrant liability         937,000    
Total liabilities         6,091,442    
Additional paid-in capital         8,256,864    
Accumulated deficit         (3,684,743)    
Total Stockholders' Equity         4,610,701    
Effects of the restatement on the Company’s statement of operations              
Mark-to-market adjustment on warrant liability   632,475   2,014,575 2,038,000    
Total Other Income (Expense)         2,070,767    
Net loss before income tax   121,185   (50,328) (1,593,173)    
Net income (loss)   121,185   (50,328) (1,593,173)    
Basic net loss per share   $ 0.00   $ 0.00 $ (0.04)    
Effect of restatement on the Company's statement of changes in stockholders' equity              
Additional paid-in capital         8,256,864    
Accumulated deficit         (3,684,743)    
Total Stockholders' Equity         4,610,701    
Effect of restatement on company's statement of cash flows              
Net income (loss)   121,185   (50,328) (1,593,173)    
Mark-to-market adjustment on warrant liability   $ (632,475)   $ (2,014,575) $ (2,038,000)